The Recall Desk
SevereFDA (Drugs)·D-0359-2015·Announced 2015-01-28

Walgreens Infusion Services Recalls Linezolid Infusions Due to Sterility Concerns

Walgreens Infusion Services is recalling Linezolid in dextrose infusions due to a lack of sterility assurance. The products were distributed in six states.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of sterility assurance in an intravenous drug, which poses a significant risk of serious injury or infection.

Plain-English summary

Walgreens Infusion Services is recalling Linezolid in dextrose infusions of various strengths. The recall was initiated due to a lack of sterility assurance for the products.

The affected products were distributed in Texas, Florida, Virginia, Georgia, Louisiana, and Mississippi. All products within their expiration dates are included in this recall.

Consumers and healthcare providers should stop using the recalled products and contact their healthcare provider for further instructions.

The recalled product

Product
Linezolid various strengths in dextrose

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All products within expiry.

Distribution

Distributed in 6 states:

Part of a larger recall action

This product is one of 36 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 36 products in this recall →